1603 related articles for article (PubMed ID: 9641677)
21. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
Kong L; Lee JH; Doores KJ; Murin CD; Julien JP; McBride R; Liu Y; Marozsan A; Cupo A; Klasse PJ; Hoffenberg S; Caulfield M; King CR; Hua Y; Le KM; Khayat R; Deller MC; Clayton T; Tien H; Feizi T; Sanders RW; Paulson JC; Moore JP; Stanfield RL; Burton DR; Ward AB; Wilson IA
Nat Struct Mol Biol; 2013 Jul; 20(7):796-803. PubMed ID: 23708606
[TBL] [Abstract][Full Text] [Related]
22. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility.
Pancera M; Majeed S; Ban YE; Chen L; Huang CC; Kong L; Kwon YD; Stuckey J; Zhou T; Robinson JE; Schief WR; Sodroski J; Wyatt R; Kwong PD
Proc Natl Acad Sci U S A; 2010 Jan; 107(3):1166-71. PubMed ID: 20080564
[TBL] [Abstract][Full Text] [Related]
23. Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain.
Wu L; Zhou T; Yang ZY; Svehla K; O'Dell S; Louder MK; Xu L; Mascola JR; Burton DR; Hoxie JA; Doms RW; Kwong PD; Nabel GJ
J Virol; 2009 May; 83(10):5077-86. PubMed ID: 19264769
[TBL] [Abstract][Full Text] [Related]
24. Molecular motions of human HIV-1 gp120 envelope glycoproteins.
Liu SQ; Liu SX; Fu YX
J Mol Model; 2008 Sep; 14(9):857-70. PubMed ID: 18594881
[TBL] [Abstract][Full Text] [Related]
25. Structural plasticity and conformational transitions of HIV envelope glycoprotein gp120.
Korkut A; Hendrickson WA
PLoS One; 2012; 7(12):e52170. PubMed ID: 23300605
[TBL] [Abstract][Full Text] [Related]
26. A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.
Xiang SH; Finzi A; Pacheco B; Alexander K; Yuan W; Rizzuto C; Huang CC; Kwong PD; Sodroski J
J Virol; 2010 Apr; 84(7):3147-61. PubMed ID: 20089638
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
[TBL] [Abstract][Full Text] [Related]
28. Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.
Rathore U; Purwar M; Vignesh VS; Das R; Kumar AA; Bhattacharyya S; Arendt H; DeStefano J; Wilson A; Parks C; La Branche CC; Montefiori DC; Varadarajan R
J Biol Chem; 2018 Sep; 293(39):15002-15020. PubMed ID: 30093409
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction.
Hinz A; Lutje Hulsik D; Forsman A; Koh WW; Belrhali H; Gorlani A; de Haard H; Weiss RA; Verrips T; Weissenhorn W
PLoS One; 2010 May; 5(5):e10482. PubMed ID: 20463957
[TBL] [Abstract][Full Text] [Related]
30. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
[TBL] [Abstract][Full Text] [Related]
31. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
32. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
[TBL] [Abstract][Full Text] [Related]
33. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.
Labrijn AF; Poignard P; Raja A; Zwick MB; Delgado K; Franti M; Binley J; Vivona V; Grundner C; Huang CC; Venturi M; Petropoulos CJ; Wrin T; Dimitrov DS; Robinson J; Kwong PD; Wyatt RT; Sodroski J; Burton DR
J Virol; 2003 Oct; 77(19):10557-65. PubMed ID: 12970440
[TBL] [Abstract][Full Text] [Related]
34. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
35. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.
Courter JR; Madani N; Sodroski J; Schön A; Freire E; Kwong PD; Hendrickson WA; Chaiken IM; LaLonde JM; Smith AB
Acc Chem Res; 2014 Apr; 47(4):1228-37. PubMed ID: 24502450
[TBL] [Abstract][Full Text] [Related]
36. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.
Liao HX; Lynch R; Zhou T; Gao F; Alam SM; Boyd SD; Fire AZ; Roskin KM; Schramm CA; Zhang Z; Zhu J; Shapiro L; ; Mullikin JC; Gnanakaran S; Hraber P; Wiehe K; Kelsoe G; Yang G; Xia SM; Montefiori DC; Parks R; Lloyd KE; Scearce RM; Soderberg KA; Cohen M; Kamanga G; Louder MK; Tran LM; Chen Y; Cai F; Chen S; Moquin S; Du X; Joyce MG; Srivatsan S; Zhang B; Zheng A; Shaw GM; Hahn BH; Kepler TB; Korber BT; Kwong PD; Mascola JR; Haynes BF
Nature; 2013 Apr; 496(7446):469-76. PubMed ID: 23552890
[TBL] [Abstract][Full Text] [Related]
37. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Trkola A; Dragic T; Arthos J; Binley JM; Olson WC; Allaway GP; Cheng-Mayer C; Robinson J; Maddon PJ; Moore JP
Nature; 1996 Nov; 384(6605):184-7. PubMed ID: 8906796
[TBL] [Abstract][Full Text] [Related]
38. Asymmetric opening of HIV-1 Env bound to CD4 and a coreceptor-mimicking antibody.
Yang Z; Wang H; Liu AZ; Gristick HB; Bjorkman PJ
Nat Struct Mol Biol; 2019 Dec; 26(12):1167-1175. PubMed ID: 31792452
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
40. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
Sattentau QJ; Moore JP
J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
